OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ARGX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

argenx SE (ARGX) Earnings Date & Reports

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

ARGX is expected to report earnings to fall 27.37% to $4.59 per share on October 30

Q3'25

Est.

$4.59

Q2'25

Beat

by $3.26

Q1'25

Beat

by $0.34

Q4'24

Beat

by $10.57

Q3'24

Beat

by $1.24

The last earnings report on July 31 showed earnings per share of $6.32, beating the estimate of $3.06. With 224.91K shares outstanding, the current market capitalization sits at 40.61B.

View a ticker or compare two or three

Compare

ARGX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ARGX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARGX showed earnings on July 31, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a manufacturer of antibody-based medicines

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

Laarderhoogtweg 25

Phone

+31 107038441

Employees

1148

Web

https://www.argenx.com